Kailyna 19.5mg (Levonorgestrel)

Adult dosage

This medication is inserted into the uterine cavity and is effective for five years after insertion. It should be inserted within 7 days of the start of menstruation, and may be replaced with a new one at any time during the menstrual cycle. After childbirth, insertion should wait until the uterus has returned to its normal state, and should not be inserted within 6 weeks after delivery. This medication should only be inserted by a healthcare professional who has experience with the insertion of intrauterine systems or has received training in the insertion process.

This medication should not be used in women who are pregnant or suspected to be pregnant. It should also not be administered to those with pelvic infections or uterine-related inflammation, or to those who have recently experienced an infectious miscarriage. The use of this medication is prohibited in patients with certain tumors, such as uterine cancer, cervical cancer, or breast cancer. It should not be used if there is unexplained abnormal uterine bleeding. Patients with uterine deformities or fibroids that interfere with the maintenance of the intrauterine system should not be treated with this medication. Patients with liver disease or liver tumors, as well as those allergic to any component of this medication, should avoid its use. This medication should be used cautiously after consulting a specialist, and immediate medical consultation is required if symptoms such as migraine, severe headache, jaundice, high blood pressure, or stroke occur. Women with heart disease or heart valve disease should take special caution when using this medication. Diabetic patients should have regular blood sugar tests as this medication may affect blood sugar levels. The use of this medication may change the pattern of menstrual bleeding, and amenorrhea or irregular bleeding may occur. During use, side effects such as headaches, depressive symptoms, abdominal pain, acne, hair loss, changes in menstrual bleeding, and spotting may occur. There may be reactions such as pain, bleeding, or fainting when inserting or removing this medication, so caution is needed. Since there is a risk of pelvic infection, it should be used only after treatment if there are sexually transmitted infections or severe infections that recur. As this medication may expel from the uterus, the thread should be checked and any abnormalities should be reported to a physician. There is a possibility of uterine perforation, so immediate examination and treatment are needed if abnormal symptoms occur after insertion. If pregnancy occurs while using this medication, the possibility of ectopic pregnancy should be confirmed, and it is recommended to remove this medication if pregnancy is confirmed. There may be drug interactions, so if other medications are being taken, consultation with a doctor or pharmacist is essential. This medication should not be used during pregnancy, and while generally safe during breastfeeding, consulting a physician is advised. Use of this medication is recommended only for women aged 18 and over, and it is not suitable for women over 65 years old or postmenopausal women. The product must be maintained in a sterile state, and should not be used if the packaging is damaged or has expired. This medication should not be reused after single use.

Serious side effects

Urticaria, angioedema, hypersensitivity reactions, marked increase in blood pressure, very severe headaches, localized migraine associated with migraines, transient ischemic attack symptoms, jaundice, severe arterial diseases (stroke, myocardial infarction), uterine perforation, sepsis, infectious endocarditis, severe pelvic infections, endometritis, ectopic pregnancy, syncope due to vagal nerve response, perforation, severe swelling or urination abnormalities.

Mild side effects

Depressive symptoms/depression, headache, migraine, abdominal pain/pelvic pain, nausea, acne/seborrhea, hair loss, hirsutism, changes in menstrual bleeding, spotting, hypomenorrhea, amenorrhea, ovarian cysts, vulvovaginitis, upper genital tract infections, dysmenorrhea, breast pain/discomfort, expulsion of the intrauterine device, genital secretions, pain and bleeding during insertion and removal, dizziness and fainting related to insertion, loss of thread, enlarged follicles, minimal imaging distortion.

This medication should be stored in a sealed container to prevent exposure to air, at a temperature between 1°C and 30°C, to maintain its effectiveness.

Appearance

It is an intrauterine system with a drug reservoir that is white or light yellow, surrounded by a translucent tube, attached to the vertical portion of the T-body. There is a ring at the end of the vertical portion of the T-body, and two ends on the other side.

Package unit

1 set